公司資料
Intelligent Bio Solutions 股價、新聞與催化劑
- 股票代碼:
- INBS
- 交易所:
- NASDAQ
- 產業:
- MedTech
- 所在地:
- United States
股票表現
3.37 USD (+21.66%)
收盤價
最後更新: 2026年8月17日
6.08M USD
市值
股價為何變動
Following the latest company update, “Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification”, INBS closed up 21.7% at $3.37 on Aug 17, 2026. The move occurred in the trading session associated with this fda / regulatory update.
公司概覽
業務概覽
Intelligent Bio Solutions is a diagnostics company focused on rapid biosensor testing and point-of-care identification. Its business centers on using sensor technology to improve screening and clinical workflows.
所在地與產業分類
Intelligent Bio Solutions is headquartered in the United States and listed on NASDAQ. It sits in diagnostics and medical devices rather than biotechnology therapeutics.
商業模式特徵
The company depends on product adoption, commercialization, and the ability to expand its testing platform across use cases. Investors usually watch device rollout, adoption, and revenue growth.
生技產業定位
Intelligent Bio Solutions is part of the diagnostics and biosensor infrastructure layer. It is not biotech, but it is relevant to the broader testing ecosystem.
未來催化劑
- Intelligent Bio Solutions’ catalysts are drug-testing and workplace-safety products, plus any commercial update that clarifies adoption. The story is about product utilization and recurring demand.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。